Lexicon Pharmaceuticals (LXRX) Change in Acquisitions & Divestments: 2009-2024
Historic Change in Acquisitions & Divestments for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $314.4 million.
- Lexicon Pharmaceuticals' Change in Acquisitions & Divestments rose 71.10% to $74.8 million in Q4 2012 from the same period last year, while for Dec 2012 it was $135.8 million, marking a year-over-year decrease of 23.09%. This contributed to the annual value of $314.4 million for FY2024, which is 80.82% up from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Change in Acquisitions & Divestments of $314.4 million as of FY2024, which was up 80.82% from $173.9 million recorded in FY2023.
- Over the past 5 years, Lexicon Pharmaceuticals' Change in Acquisitions & Divestments peaked at $314.4 million during FY2024, and registered a low of $37.6 million during FY2021.
- Its 3-year average for Change in Acquisitions & Divestments is $184.2 million, with a median of $173.9 million in 2023.
- In the last 5 years, Lexicon Pharmaceuticals' Change in Acquisitions & Divestments crashed by 85.97% in 2021 and then spiked by 170.84% in 2023.
- Yearly analysis of 5 years shows Lexicon Pharmaceuticals' Change in Acquisitions & Divestments stood at $268.0 million in 2020, then plummeted by 85.97% to $37.6 million in 2021, then spiked by 70.77% to $64.2 million in 2022, then spiked by 170.84% to $173.9 million in 2023, then soared by 80.82% to $314.4 million in 2024.